Literature DB >> 1994709

Hypertension, endothelium, and cardiovascular risk factors.

L Raij1.   

Abstract

The functions of the endothelium and the effects of hypertension, atherosclerosis, and diabetes on the endothelium are reviewed. The endothelium affects vascular tone by releasing vasodilators and modulating the effects of vasoactive substances such as catecholamines, bradykinin, serotonin, and angiotensin II. Relaxation of vascular smooth muscle depends upon a functionally intact endothelium and the release of the endothelium-derived relaxing factor nitric oxide. Endothelial cells also appear to release a hyperpolarizing factor that relaxes smooth muscle through activation of the sodium-potassium pump, and of the endothelium-dependent contracting factors. Similarities are found in the vascular injury resulting from hypertension, atherosclerosis, and diabetes. When these risk factors coexist, they can act synergistically and magnify the vascular injury. The endothelium appears to be one of the major targets for these forms of injury. Future therapeutic strategies will focus on ways to prevent, arrest, or reverse endothelial injury.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1994709     DOI: 10.1016/0002-9343(91)90029-w

Source DB:  PubMed          Journal:  Am J Med        ISSN: 0002-9343            Impact factor:   4.965


  3 in total

Review 1.  Cardiovascular determinants of life span.

Authors:  Yi Shi; Giovanni G Camici; Thomas F Lüscher
Journal:  Pflugers Arch       Date:  2009-09-12       Impact factor: 3.657

2.  Protective effect and mechanism of rat recombinant S100 calcium-binding protein A4 on oxidative stress injury of rat vascular endothelial cells.

Authors:  Xiangyan Meng; Xiujie Gao; Zhiqing Zhang; Xuesi Zhou; Lei Wu; Miaomiao Yang; Kun Wang; Hanlin Ren; Bei Sun; Tianhui Wang
Journal:  Oncol Lett       Date:  2018-07-11       Impact factor: 2.967

3.  Valsartan improves endothelial dysfunction in hypertension: a randomized, double-blind study.

Authors:  Nikolaos Tzemos; Pitt O Lim; Thomas M MacDonald
Journal:  Cardiovasc Ther       Date:  2009-07-14       Impact factor: 3.023

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.